Doug Jones

1)  Charlene–gentle clarification re: COVID-19 terminology.  COVID-19 is the name given to the disease which is caused by a particular NEW corona virus–<span style=”color: #000000; font-family: ‘Open Sans’, apple-system, blinkmacsystemfont, ‘Segoe UI’, ‘Helvetica Neue’, arial, sans-serif; font-size: 17px;”> </span><span style=”color: #000000; fo…[Read more]

For those interested in the formal recommendations from the American College of Chest Physicians, you may want to check out this article from CHEST–their official, refereed publication from 2018; below is an abstract of the article..

Doug Jones

Treatment of Interstitial Lung Disease Associated Cough:  CHEST Guideline and Expert Panel Report.   …[Read more]

These response are interesting; glad that gabapentin may work for some.  I note that the research study cited from Lancet EXLCLUDED chronic coughers who had a respiratory disease so its effectiveness for IPF patients may not be the same–see excerpt below.  The medical literature shows mixed results for gabapentin in controlling cough–plus a v…[Read more]

Consumer Reports recently reported on “The Best Flu Treatment for You”  which includes many of the suggestions noted in the previous comments.  However, Elderberry has very limited research support so I would be skeptical of that.  See the full report at https://www.consumerreports.org/flu/the-best-flu-treatment-for-you/
<p style=”box-sizing: bor…[Read more]

Regarding “Off-label” use of a drug, the October 2019 issue of AARP Bulletin (page 36) has the following information and link to determine if a drug is being used “off-label”, that is, for a purpose it was not originally validated to treat.

“At DailyMed.nim.nih.gov   you can check if the drugs you’re currently taking are off-label for your d…[Read more]

I will be attending the PFF Summit and plan to take some informal notes to share with my local Pulmonary Fibrosis Support Group.  Doug